Disclosed are NK1 antagonists having the formula: ##STR1## Also disclosed are methods for treating a number of physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough, using the compounds of formula (I).
Disclosed are NK1 antagonists having the formula: ##STR1##
Also disclosed are methods for treating a number of physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough, using the compounds of formula (I).
Web www.patentalert.com
< Molecular interaction sites of interleukin-2 RNA and methods of modulating the same
< Secreted and transmembrane polypeptides and nucleic acids encoding the same
> Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1, 4-benzodiozan
> C3b/C4b Complement Receptor-like molecules and uses thereof
HOME | NEW USER | LOGIN | SUBSCRIPTIONS | SEARCH | GUESTBOOK | CONTACT
